Second Illness for Meningitis Sufferers

    This photo provided Oct. 9, 2012, by the Minnesota Department of Health shows shows vials of the injectable steroid product made by New England Compounding Center implicated in a fungal meningitis outbreak that were being shipped to the Centers for Disease Control and Prevention in Atlanta from Minneapolis. About 17,700 single-dose vials of the steroid sent to 23 states have been recalled. The outbreak involves 10 states, including Minnesota. (AP Photo/Minnesota Department of Health)

    Minnesota Department of Health / AP Photo

    Just when they thought they were safe, some patients recovering from the meningitis linked to a fungus-contaminated drug are falling ill again. Sufferers of the new infection are now coping with epidural abscesses, infections near the base of the spine where the drug was initially injected. Although the abscesses are localized, they are painful and occurred despite the strong antifungal medications patients were already taking, forcing them back into the hospital for more treatment and surgery. Over 400 cases of the meningitis have been reported nationwide so far.

    Read it at The New York Times